XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.1
Note 8 - Accrued Liabilities
 9 Months Ended
Mar. 31, 2025
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

Note 8 - Accrued Liabilities

 

Accrued liabilities consist of the following:

 

  

March 31,

  

June 30,

 
  

2025

  

2024

 
  

(in thousands)

 

Accrued savings offers

 $17,506  $11,054 

Accrued program liabilities

  7,116   9,964 

Accrued customer and product related fees

  4,719   5,395 

Return reserve

  6,545   4,832 

Accrued employee compensation

  3,993   4,603 

Other accrued liabilities

  1,848   2,295 

Total accrued liabilities

 $41,727  $38,143 

 

Accrued savings offers represent programs for the Company’s patients covered under commercial payor plans in which the cost of a prescription to such patients is discounted. Accrued program liabilities include government and commercial rebates. Accrued customer and product related fees include accrued expenses and deductions for rebates, wholesaler chargebacks and fees, and other product-related fees and deductions such as royalties for Pediatric Portfolio products, accrued distributor fees, and Medicaid liabilities. The return reserve represents the Company’s accrual for estimated product returns. Accrued employee compensation includes sales commissions, paid time off earned, accrued payroll and accrued bonus. Other accrued liabilities consist of various other accruals, none of which individually or in the aggregate represent greater than five percent of total liabilities.